Search by Drug Name or NDC
NDC 00002-7589-01 Bebtelovimab 87.5 mg/mL Details
Bebtelovimab 87.5 mg/mL
Bebtelovimab is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is BEBTELOVIMAB.
MedlinePlus Drug Summary
Bebtelovimab injection is used to treat COVID-19 infection in certain non-hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) and who have mild to moderate COVID-19 symptoms. It is used in people who have certain medical conditions that make them at higher risk for developing severe COVID-19 symptoms, including the need to be hospitalized from COVID-19 infection or death. Bebtelovimab is in a class called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body in order to stop the spread of the virus.
Related Packages: 00002-7589-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Bebtelovimab Injection
Product Information
| NDC | 00002-7589 |
|---|---|
| Product ID | 0002-7589_0a45f258-0828-4a0c-b992-a8ba521b84d0 |
| Associated GPIs | 19502022002020 |
| GCN Sequence Number | 083067 |
| GCN Sequence Number Description | bebtelovimab VIAL 175MG/2 ML INTRAVEN |
| HIC3 | W5D |
| HIC3 Description | ANTIVIRAL MONOCLONAL ANTIBODIES |
| GCN | 51908 |
| HICL Sequence Number | 047815 |
| HICL Sequence Number Description | BEBTELOVIMAB |
| Brand/Generic | Generic |
| Proprietary Name | Bebtelovimab |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bebtelovimab |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 87.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | BEBTELOVIMAB |
| Labeler Name | Eli Lilly and Company |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | EMERGENCY USE AUTHORIZATION |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00002-7589-01 (00002758901)
| NDC Package Code | 0002-7589-01 |
|---|---|
| Billing NDC | 00002758901 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7589-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-02-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |